Pharmaceutical industry news

#CONVEGNO [29.10] Umano, troppo Umano, Transumano: fino a dove può spingersi la medicina?

No classes on 20 and 24 November due to 2026 November Festival

Deadline extended: KU-STAR Program for Australia 2027

Designing Clinical Trials Around the Patient Journey

Applied Biologics Activates First Clinical Site in Phase 3 BIOxHEAL™ Trial

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Novartis (NVS) Stock Surges 5% Following Positive Multiple Sclerosis Drug Trial Results

Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP

Invivyd Names Marc Elia CEO, Adds New Independent Director as VYD2311 Phase 3 Studies Near Completion

Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Ocugen Doses First Patient in OCU410 Phase 3 Trial | OCGN Stock News

AI, Naloxone and Drug Labels: Medication Safety Pearls from ASHP Meeting

Harmonizing Data Collection for Precision Oncology: AACR Project GENIE® Data Model

NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier

Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP

Weight loss supplement recalled over toxic substance, other undeclared ingredient

Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidance

Medtronic Announces Strategic Partnership with Cornerstone Robotics to Further Expand Global Access to Robotic-Assisted Surgery

UNAIDS, SADC and China, partner to advance local pharmaceutical manufacturing and health security in Southern Africa

BriaCell Therapeutics Corp. (TSX:BCT) Falls 4.24% as Clinical-Stage Risk and Volatility Pressure Sentiment

Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial

Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660

Trump signs MFN agreements with nine new companies

China in Global Clinical Development: Why Early Inclusion Matters

Weight-Loss Supplement Recalled Nationwide After FDA Finds Undisclosed Drug, Toxic Chemical

Wall Street's momentum trade is unraveling as chip stocks slide and biotech makes a comeback

GSK catches phase 3 fever after mRNA flu vaccine beats standard shots

Ondine Biomedical share price rallies following 40% drop in surgical infections

Russia experiencing shortage of hemophilia B drugs

Kuwait Cuts Prices of 517 Medicines & Pharmaceutical Products

Lung cancer combo succeeds in first-line China trial

A political scientist’s view on the election in Saxony-Anhalt: “We need to rethink our expectations”

Election researcher on the Saxony-Anhalt election: “Where emotions dominate, facts carry little weight”

HiRO and Differentia Biotech collaborate on clinical trial simulation

Adult Social Care Learning and Development Support Scheme: a guide for employers

Information for adult social care employers in England on learning and development support.

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Average Rating of "Moderate Buy" from Analysts

Corient Private Wealth LP Acquires New Shares in Ultragenyx Pharmaceutical Inc. $RARE

Ondine Biomedical share price rallies following 40% drop in surgical infections

Adult social care provider statistics, England: quarterly update to August 2026

Official statistics on the number of people receiving adult social care services, and information on...

Daiichi Sankyo advances AAX Biotech’s Opti-mAb into antibody program

Hsbc Holdings PLC Takes $1.53 Million Position in Ultragenyx Pharmaceutical Inc. $RARE

Biotech Stocks At 52-Week Highs - RNXT +15%, EOLS, CRNX, APGE

Bank of New York Mellon Corp Makes New Investment in Ultragenyx Pharmaceutical Inc. $RARE

Nature Medicine’s 38,753-Patient HF Synthesis Signals a Replicable Model for RWE-Driven Label Expansion Without New RCTs

Trump touts latest drug discount deals

New Oral Weight-Loss Pill Delivers 12% Body Loss Without Injections or Fasting

À partir du 1e septembre 2026 : nouvelle version du formulaire de demande d'autorisation de mise sur le marché pour les procédures nationales, de reconnaissance mutuelle et décentralisées

Gratis pneumokockvaccin till alla 65 år eller äldre i Västra Götaland

IDEAYA gets FDA nod on Phase 3 design for lung-cancer drug IDE849

Cadrenal aligns with FDA on Phase 3 design for blood-clotting drug CAD-1005

GSK to advance mRNA seasonal flu vaccine candidate to phase III following positive phase II data

UC Davis Health launches fellowship programs in pediatric cardiology and pediatric hospital medicine

A second chance at life started with an unexpected gift

Why Europe must seize the biotechnology opportunity

JIANGXI BIO Announced 2026 Interim Results

Canada’s Drug Agency Issues Positive Reimbursement Recommendation for Lecanemab

XYRA doses first European patient in Phase 2/3 trial of AF drug budiodarone

SLS, IBRX Stocks Post August Gains: Eli Lilly’s Latest $2.9B Deal Has Retail Traders Bracing For An ‘M&A Rampage’

SLS, IBRX Stocks Post August Gains: Eli Lilly’s Latest $2.9B Deal Has Retail Traders Bracing For An ‘M&A Rampage’

Eascra Biotech Wins $7.96 Million NASA Award to Advance Space-Based Medicine Manufacturing